These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 31347950

  • 1. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
    Pecoraro A, Palumbo C, Knipper S, Mistretta FA, Tian Z, Shariat SF, Saad F, Briganti A, Fiori C, Porpiglia F, Karakiewicz PI.
    J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
    [Abstract] [Full Text] [Related]

  • 2. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, Gao T, Kaouk JH.
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [Abstract] [Full Text] [Related]

  • 3. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
    Palumbo C, Cyr SJ, Mazzone E, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Kapoor A, Antonelli A, Karakiewicz PI.
    J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [Abstract] [Full Text] [Related]

  • 5. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
    Meskawi M, Becker A, Bianchi M, Trinh QD, Roghmann F, Tian Z, Graefen M, Perrotte P, Karakiewicz PI, Sun M.
    Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
    [Abstract] [Full Text] [Related]

  • 6. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 7. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
    Tanagho YS, Bhayani SB, Kim EH, Figenshau RS.
    J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
    [Abstract] [Full Text] [Related]

  • 8. Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.
    Liao X, Qiu S, Wang W, Zheng X, Jin K, Zhang S, Bao Y, Yang L, Wei Q.
    Cancer Epidemiol; 2019 Apr; 59():221-226. PubMed ID: 30836219
    [Abstract] [Full Text] [Related]

  • 9. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [Abstract] [Full Text] [Related]

  • 10. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
    Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, Weisbrod AJ, Schmit GD, Thompson RH.
    Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
    [Abstract] [Full Text] [Related]

  • 11. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
    Mazzone E, Nazzani S, Preisser F, Tian Z, Marchioni M, Bandini M, Capitanio U, Kapoor A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, I Karakiewicz P.
    Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
    [Abstract] [Full Text] [Related]

  • 12. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
    Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, Leibovich BC, Schmit GD, Thompson RH.
    BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
    [Abstract] [Full Text] [Related]

  • 13. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [Abstract] [Full Text] [Related]

  • 14. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL, Hayn MH, Brewer KA, Underwood W, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T.
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [Abstract] [Full Text] [Related]

  • 15. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
    Lee H, Oh JJ, Byun SS, Jeong CW, Kwak C, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
    [Abstract] [Full Text] [Related]

  • 16. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
    Klatte T, Mauermann J, Heinz-Peer G, Waldert M, Weibl P, Klingler HC, Remzi M.
    J Endourol; 2011 Jun; 25(6):991-7. PubMed ID: 21568698
    [Abstract] [Full Text] [Related]

  • 17. Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis.
    Yanagisawa T, Miki J, Shimizu K, Fukuokaya W, Urabe F, Mori K, Sasaki H, Kimura T, Miki K, Egawa S.
    Urol Oncol; 2020 Dec; 38(12):938.e1-938.e7. PubMed ID: 33036899
    [Abstract] [Full Text] [Related]

  • 18. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C, Mistretta FA, Knipper S, Mazzone E, Pecoraro A, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lavallee LT, Karakiewicz PI.
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [Abstract] [Full Text] [Related]

  • 19. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study.
    Siech C, Incesu RB, Morra S, Scheipner L, Baudo A, Jannello LMI, de Angelis M, Goyal JA, Tian Z, Saad F, Shariat SF, Tilki D, Longo N, Carmignani L, de Cobelli O, Ahyai S, Briganti A, Mandel P, Kluth LA, Chun FKH, Karakiewicz PI.
    Surg Oncol; 2024 Apr; 53():102047. PubMed ID: 38359547
    [Abstract] [Full Text] [Related]

  • 20. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD.
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.